Views & Analysis Rebooting the healthcare system post-COVID-19 Janssen’s Iris Zemzoum looks at seven ways the healthcare and pharma sectors need to change in the wake of COVID-19.
Views & Analysis Janssen: ‘Open dialogue’ needed with HTAs to improve access The world of life sciences is changing rapidly, and the traditional ways of assessing drugs may no longer be fit for purpose.
News J&J brings forward start of COVID-19 vaccine trial to next m... Johnson & Johnson has announced it has brought forward the start of its COVID-19 vaccine by around two months to mid-July.
Views & Analysis Deep Dive: Market Access - Breaking Barriers In this issue of Deep Dive we look at the changing landscape for pharma market access and start to assess the impact of the COVID-19 pandemic.
Views & Analysis Janssen’s Gaëtan Leblay on leading during the COVID-19 crisi... COVID-19 is putting unimaginable pressure on healthcare systems and the companies looking for solutions to end the pandemic.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
